Biophysical properties of the isolated spike protein binding helix of human ACE2.


Journal

Biophysical journal
ISSN: 1542-0086
Titre abrégé: Biophys J
Pays: United States
ID NLM: 0370626

Informations de publication

Date de publication:
20 07 2021
Historique:
received: 10 12 2020
revised: 22 04 2021
accepted: 17 06 2021
pubmed: 3 7 2021
medline: 27 7 2021
entrez: 2 7 2021
Statut: ppublish

Résumé

The entry of the severe acute respiratory syndrome coronavirus 2 virus in human cells is mediated by the binding of its surface spike protein to the human angiotensin-converting enzyme 2 (ACE2) receptor. A 23-residue long helical segment (SBP1) at the binding interface of human ACE2 interacts with viral spike protein and therefore has generated considerable interest as a recognition element for virus detection. Unfortunately, emerging reports indicate that the affinity of SBP1 to the receptor-binding domain of the spike protein is much lower than that of the ACE2 receptor itself. Here, we examine the biophysical properties of SBP1 to reveal factors leading to its low affinity for the spike protein. Whereas SBP1 shows good solubility (solubility > 0.8 mM), circular dichroism spectroscopy shows that it is mostly disordered with some antiparallel β-sheet content and no helicity. The helicity is substantial (>20%) only upon adding high concentrations (≥20% v/v) of 2,2,2-trifluoroethanol, a helix promoter. Fluorescence correlation spectroscopy and single-molecule photobleaching studies show that the peptide oligomerizes at concentrations >50 nM. We hypothesized that mutating the hydrophobic residues (F28, F32, and F40) of SBP1, which do not directly interact with the spike protein, to alanine would reduce peptide oligomerization without affecting its spike binding affinity. Whereas the mutant peptide (SBP1

Identifiants

pubmed: 34214538
pii: S0006-3495(21)00504-X
doi: 10.1016/j.bpj.2021.06.017
pmc: PMC8241576
pii:
doi:

Substances chimiques

Spike Glycoprotein, Coronavirus 0
Peptidyl-Dipeptidase A EC 3.4.15.1
Angiotensin-Converting Enzyme 2 EC 3.4.17.23

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2785-2792

Informations de copyright

Copyright © 2021 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Anirban Das (A)

Department of Chemical Sciences, Tata Institute of Fundamental Research, Colaba, Mumbai, India.

Vicky Vishvakarma (V)

Department of Chemical Sciences, Tata Institute of Fundamental Research, Colaba, Mumbai, India.

Arpan Dey (A)

Department of Chemical Sciences, Tata Institute of Fundamental Research, Colaba, Mumbai, India.

Simli Dey (S)

Department of Chemical Sciences, Tata Institute of Fundamental Research, Colaba, Mumbai, India.

Ankur Gupta (A)

Department of Chemical Sciences, Tata Institute of Fundamental Research, Colaba, Mumbai, India.

Mitradip Das (M)

Department of Chemical Sciences, Tata Institute of Fundamental Research, Colaba, Mumbai, India.

Krishna Kant Vishwakarma (KK)

Department of Chemical Sciences, Tata Institute of Fundamental Research, Colaba, Mumbai, India.

Debsankar Saha Roy (DS)

Department of Chemical Sciences, Tata Institute of Fundamental Research, Colaba, Mumbai, India.

Swati Yadav (S)

National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, Karnataka, India.

Shubham Kesarwani (S)

Centre for Cardiovascular Biology and Disease, Institute of Stem Cell Science and Regenerative Medicine (inStem), Gandhi Krishi Vigyan Kendra Campus, Bangalore, Karnataka, India.

Ravindra Venkatramani (R)

Department of Chemical Sciences, Tata Institute of Fundamental Research, Colaba, Mumbai, India.

Sudipta Maiti (S)

Department of Chemical Sciences, Tata Institute of Fundamental Research, Colaba, Mumbai, India. Electronic address: maiti@tifr.res.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH